Home β€Ί Stock analysis β€Ί CDIO

Cardio Diagnostics (CDIO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

CDIO jumps 5.4% to $1.76. Closed at $1.76, +5.39% vs the prior close of $1.67. Day range $1.67–$1.84, opened at $1.67.

Last close$1.76+5.39%
Day range1.67–1.84
Open1.67
Volume27.30K
52-week range0.97–7.91
Avg volume (20d)31.47K

CDIO daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” CDIO jumps 5.4% to $1.76
Oct 14, 2026 β€” CDIO slides 4.6% to $1.67, a 1-month low, 3 down days in a row
Oct 13, 2026 β€” CDIO dips 1.7% to $1.75, a 1-month low
Oct 12, 2026 β€” CDIO slides 4.8% to $1.78, a 1-month low
Oct 9, 2026 β€” CDIO rises 0.5% to $1.87
Oct 8, 2026 β€” CDIO slides 5.1% to $1.86, a 1-month low, 3 down days in a row
Oct 7, 2026 β€” CDIO dips 2.0% to $1.96
Oct 6, 2026 β€” CDIO dips 2.9% to $2.00
Oct 5, 2026 β€” CDIO jumps 5.1% to $2.06, 4 up days in a row
Oct 2, 2026 β€” CDIO rises 2.1% to $1.96, 3 up days in a row

CDIO latest news & SEC filings

Every SEC filing by or about CDIO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002055040-26-000004

Oct 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002060369-26-000004

Oct 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001950394-26-000004

Oct 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002006956-26-000004

Sep 18, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001553350-26-000131

Sep 8, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001079973-26-001223

Aug 20, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001079973-26-001153

Aug 7, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001079973-26-001016

Aug 7, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001079973-26-001010

Aug 5, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001079973-26-001003

Jul 23, 2026 Β· Form ARS β€” Annual report to shareholders

Annual report to shareholders

Source: SEC EDGAR filing 0001079973-26-000965

Jul 13, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001079973-26-000945

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002060369-26-000003

Jul 2, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002055040-26-000003

Things to know before you trade CDIO

CDIO market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20261.671.841.671.7627.30K
Oct 14, 20261.771.781.671.6731.90K
Oct 13, 20261.861.861.751.7519.80K
Oct 12, 20261.901.911.651.7861.60K
Oct 9, 20261.901.951.871.8716.40K
Oct 8, 20261.991.991.851.8657.30K
Oct 7, 20262.002.031.951.9630.20K
Oct 6, 20262.022.071.982.0020.90K
Oct 5, 20261.982.231.982.0639.10K
Oct 2, 20261.971.971.861.9626.10K
Oct 1, 20261.881.951.881.9216.80K
Sep 30, 20261.872.021.851.9033.50K
Sep 29, 20261.911.921.851.8737.80K
Sep 28, 20261.941.951.881.8910.30K
Sep 25, 20261.901.971.891.9538.90K
Sep 24, 20261.931.971.891.9117.60K
Sep 23, 20261.982.031.871.9232.60K
Sep 22, 20261.941.961.911.9216.00K
Sep 21, 20262.072.071.911.9223.70K
Sep 18, 20262.042.161.922.0271.60K

About Cardio Diagnostics

Cardio Diagnostics (CDIO) is listed on the Nasdaq and classified by the SEC under β€œIn Vitro & In Vivo Diagnostic Substances”. Its business address is in CHICAGO, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1870144.

CDIO board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Wendy J BettsDirectorJul 2, 2026
Paul Frederick BurtonDirectorJul 2, 2026
Peter K FungDirectorJul 2, 2026
James IntraterDirectorJul 2, 2026

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

CDIO financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$14.82K$-6.50M-3.71$-5.73M
Dec 31, 2024$34.89K$-8.38M-9.35$-4.99M
Dec 31, 2023$17.07K$-8.38M-0.66$-5.67M
Dec 31, 2022$950$-4.66M-1.51$-5.09M
Dec 31, 2021$901$-620.45K-0.53$-585.29K

Latest balance sheet: total assets $7.93M, total liabilities $499.78K, cash $0 (as of Jun 30, 2026).

CDIO earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· In Vitro & In Vivo Diagnostic Substances

Idexx Laboratories (IDXX)Lantheus (LNTH)Intellia Therapeutics (NTLA)Neogen (NEOG)Celldex Therapeutics (CLDX)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Insight Molecular Diagnostics (IMDX)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on CDIO

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.